Related Experiment Videos
Taurine-diabetes interaction: from involvement to protection
Sung-Jin Kim1, Ramesh C Gupta, Hyeon Woo Lee
1Dept. of Pharmacology and Metabolic Diseases Research Laboratory, School of Dentistry, Kyung Hee University, Seoul 130-701, Korea. kimsj@khu.ac.kr
Current Diabetes Reviews
|January 29, 2008
Summary
Taurine, an amino acid, shows promise in managing diabetes by supporting insulin function and preventing complications. Further research into taurine analogues could offer new therapeutic avenues for diabetes treatment and prevention.
Area of Science:
- Endocrinology
- Nutritional Science
- Metabolic Disorders
Background:
- Diabetes mellitus is a complex metabolic disorder with significant health implications.
- Nutritional interventions, including amino acid supplementation, offer potential therapeutic strategies.
- Taurine, an abundant amino acid, plays a role in insulin regulation and possesses protective properties relevant to diabetes.
Purpose of the Study:
- To review the multifaceted role of taurine in diabetes mellitus.
- To explore taurine's potential in preventing diabetes and its associated complications.
- To discuss the mechanisms underlying taurine's hypoglycemic and protective effects.
Main Methods:
- Literature review of studies investigating taurine's effects on diabetes.
- Analysis of taurine's involvement in insulin secretion, action, and protection of the insulin apparatus.
- Examination of clinical evidence for taurine supplementation in diabetic complications (neuropathy, retinopathy, etc.).
Main Results:
- Taurine exhibits mutual stimulating actions with insulin, leading to hypoglycemic effects.
- Supplementation with taurine demonstrates beneficial effects on platelet aggregation and diabetic complications.
- Emerging evidence suggests taurine's role in fetal development and preventing mother-to-offspring diabetes transmission.
Conclusions:
- Taurine holds significant potential as a therapeutic agent for diabetes management and prevention.
- Understanding taurine's mechanisms, including osmoregulation and anti-oxidation, is crucial.
- Developing taurine analogues presents a promising avenue for alternative diabetes therapies, addressing limitations of current treatments.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...